Efficacy of ultra-short, response-guided sofosbuvir and daclatasvir therapy for hepatitis C in a...
Shortened hepatitis C therapy, with retreatment if needed, can reduce antiviral drug use in patients with mild liver disease, but day 2 viral load is not an adequate predictor of outcome.
elifesciences.org